Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3

被引:16
|
作者
Pirazzoli, P
Cacciari, E
DeIasio, R
Pittalis, MC
Dallacasa, P
Zucchini, S
Gualandi, S
Salardi, S
David, C
Boschi, S
机构
[1] UNIV BOLOGNA, ST ORSOLA HOSP, CENT LAB, DEPT PAEDIAT, I-40126 BOLOGNA, ITALY
[2] UNIV BOLOGNA, INST OBSTET & GYNAECOL, PRENATAL PATHOPHYSIOL UNIT, I-40126 BOLOGNA, ITALY
[3] UNIV BOLOGNA, CLIN PHARMACOL UNIT, I-40126 BOLOGNA, ITALY
关键词
insulin-like growth factor I; IGF-binding protein; growth hormone-binding protein; somatotropin;
D O I
10.1136/fn.77.2.F100
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aims-To evaluate the developmental pattern of fetal growth hormone (GH), insulin-like growth factor I (IGF-I), GH binding protein (GHBP) and IGF binding protein-3 (IGF-3); to determine the implications for fetal growth. Methods-Serum GH, IGF-I, GHBP and IGFBP-3 were measured in 53 fetuses, 41 aged 20-26 weeks (group A) and 12 aged 31-38 weeks (group B). Fetal blood samples were obtained by direct puncture of the umbilical vein in utero. Fetal blood samples were taken to rule out beta thalassaemia, chromosome alterations, mother to fetus transmissible infections, and for maternal rhesus factor. GHBP was determined by gel filtration chromatography of serum incubated overnight with I-125-GH. GH, IGF-I and IGFBP-3 were determined by radioimmunoassay. Results-Fetal serum GH concentrations in group A (median 29 mu g/l, range 11-92) were significantly higher (P<0.01) than those of group B (median 16.7 mu g/l, range 4.5-29). IGF-I in group A (median 20 mu g/l, range 4.1-53.3) was significantly lower (P<0.01) than in group B (median 75.2 mu g/l, range 27.8-122.3). IGFBP-3 concentrations in group A (median 950 mu g/l, range 580-1260) were significantly lower than those of group B (median 1920 mu g/l, range 1070-1770). There was no significant difference between GHBP values in group A (median 8.6%, range 6.6-12.6) and group B (median 8.3%, range 6-14.3). Gestational age correlated positively with IGF-I concentrations (P<0.0001) and IGFBP-3 (P<0.0001) and negatively with GH (P<0.0001). GHBP values did not correlate with gestational age. Multiple regression analysis showed a negative correlation between GH:IGF-I ratio and fetal growth indices. Conclusions The simultaneous evaluation of fetal GH, IGF-I, IGFBP-3 and GHBP suggests that the GH-IGF-I axis might already be functional in utero. The progressive improvement in the efficiency of this axis in the last part of gestation does not seem to be due to an increase in GH receptors.
引用
下载
收藏
页码:F100 / F104
页数:5
相关论文
共 50 条
  • [41] Extracorporeal losses of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in adult patients on CAPD
    Kagan, A
    Altman, Y
    Zadik, Z
    BarKhayim, Y
    ADVANCES IN PERITONEAL DIALYSIS/1997, VOL 13: SELECTED PAPERS FROM THE SEVENTEENTH ANNUAL CONFERENCE ON PERITONEAL DIALYSIS, DENVER, COLORADO, FEBRUARY 1997, 1997, 13 : 47 - 52
  • [42] Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 Cotreatment versus Insulin-Like Growth Factor-I Alone in Two Brothers with Growth Hormone Insensitivity Syndrome: Effects on Insulin Sensitivity, Body Composition and Linear Growth
    Ekstrom, Klas
    Carlsson-Skwirut, Christine
    Ritzen, E. Martin
    Bang, Peter
    HORMONE RESEARCH IN PAEDIATRICS, 2011, 76 (05): : 355 - 366
  • [43] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma
    Park, Sungshim Lani
    Setiawan, Veronica Wendy
    Kanetsky, Peter A.
    Zhang, Zuo-Feng
    Wilkens, Lynne R.
    Kolonel, Laurence N.
    Le Marchand, Loic
    CANCER CAUSES & CONTROL, 2011, 22 (09) : 1267 - 1275
  • [44] Reproducibility of serum leptin, insulin-like growth factor-I, and insulin-like growth factor-binding protein-3 measurements
    Chia, Victoria M.
    Newcomb, Polly A.
    White, Emily
    Zheng, Yingye
    Potter, John D.
    Lampe, Johanna W.
    HORMONE RESEARCH, 2008, 69 (05) : 295 - 300
  • [45] Insulin-like Growth Factor-I Gene and Insulin-like Growth Factor Binding Protein-3 Polymorphism in Patients with Thyroid Dysfunction
    Kursunluoglu, Raziye
    Turgut, Sebahat
    Akin, Fulya
    Bastemir, Mehmet
    Kaptanoglu, Buenyamin
    Genc, Osman
    Turgut, Guenfer
    ARCHIVES OF MEDICAL RESEARCH, 2009, 40 (01) : 42 - 47
  • [46] Insulin-like growth factor-I and insulin-like growth factor binding protein-3 serum levels in ankylosing spondylitis.
    Toussirot, E
    Nguyen, NU
    Dumoulin, G
    Regnard, J
    Wendling, D
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S305 - S305
  • [47] Transferrin is an insulin-like growth factor-binding protein-3 binding protein
    Weinzimer, SA
    Gibson, TB
    Collett-Solberg, PF
    Khare, A
    Liu, BR
    Cohen, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04): : 1806 - 1813
  • [48] Insulin-Like Growth Factor-I, Insulin-Like Growth factor Binding Protein-3 and Blood Hemoglobin Concentration in an Elderly Population
    Duron, Emmanuelle
    Vidal, Jean-Sebastien
    Funalot, Benoit
    Brunel, Nadege
    Viollet, Cecile
    Rigaud, Anne-Sophie
    Labouree, Florian
    Epelbaum, Jacques
    le Bouc, Yves
    Hanon, Olivier
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2015, 70 (07): : 854 - 859
  • [49] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 are not useful markers of prostate cancer
    Zancan, M.
    Dittadi, R.
    Scattoni, V.
    Fandella, A.
    Del Bianco, P.
    Gion, M.
    EJC SUPPLEMENTS, 2007, 5 (08): : 36 - 36
  • [50] Serum concentrations of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in patients with chronic hepatitis
    Okan, A
    Çömlekçi, A
    Akpmar, H
    Okan, I
    Yesil, S
    Tankurt, E
    Simsek, I
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (11) : 1212 - 1215